WBA
38
3
AMAT
60
-3
CAG
48
2
OMC
68
2
WDC
54
-3
TRV
49
4
WEC
48
2
REGN
64
-2
STI
26
6
DG
38
6
EMR
57
-5
FOXA
46
-2
CAT
66
-6
QRVO
38
-2
LOW
58
-3
HPE
48
-2
GM
82
2
EL
59
3
PSX
45
-2
GIS
61
4
WBA
38
3
AMAT
60
-3
CAG
48
2
OMC
68
2
WDC
54
-3
TRV
49
4
WEC
48
2
REGN
64
-2
STI
26
6
DG
38
6
EMR
57
-5
FOXA
46
-2
CAT
66
-6
QRVO
38
-2
LOW
58
-3
HPE
48
-2
GM
82
2
EL
59
3
PSX
45
-2
GIS
61
4
Financhill
Back

Nike Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
39

NKE
Nike

Last Price:
92.03
Seasonality Move:
3.26%
Sell
40

ITCI
Intra-Cellular Therapies

Last Price:
65.25
Seasonality Move:
-0.94%
Sell
39
Nike (NKE) is a Sell

Is Nike a Buy, Sell or Hold?

  • The current Nike [NKE] share price is $91.77. The Score for NKE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $66.53. The Score for ITCI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NKE Stock Price Chart

What is Nike's stock price today?

  • The Nike share price today is $91.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKE is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $66.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

NKE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 44.26 Sell
Chaikin Money Flow: -8013324 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.93 - 94.45) Sell
Bollinger Bands (100): (93.33 - 104.45) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.11 Sell
Relative Strength Index (14 RSI): 43.73 Sell
Chaikin Money Flow: 207665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.48 - 74.3) Sell
Bollinger Bands (100): (66.15 - 72.27) Sell

NKE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.58 Sell
20-day SMA: 93.03 Sell
50-day SMA: 94.23 Sell
200-day SMA: 101.64 Sell
8-day EMA: 92.33 Sell
20-day EMA: 92.81 Sell
50-day EMA: 94.79 Sell
200-day EMA: 101.82 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.76 Sell
20-day SMA: 70.02 Sell
50-day SMA: 68.75 Sell
200-day SMA: 62.74 Buy
8-day EMA: 67.09 Sell
20-day EMA: 68.63 Sell
50-day EMA: 69 Sell
200-day EMA: 64.65 Buy

Nike Earnings Growth & NKE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.24 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.44 per share.

Nike Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):